SureTrader SureTrader
Home > Boards > US Listed > Biotechs > Arena Pharmaceuticals, Inc. (ARNA)

Keep In This in Mind....

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
centurycom Member Profile
 
Followed By 12
Posts 1,733
Boards Moderated 0
Alias Born 12/17/04
160x600 placeholder
Advertisement
Arena Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference "PR Newswire (US)" - 5/26/2015 8:00:00 AM
Orexigen Therapeutics, Inc. Goes From Biotech Beauty to Dreadful Drugmaker "The Motley Fool" - 5/16/2015 11:04:02 AM
Which of These Growth Stocks Is Most Worthy of Your Money? "The Motley Fool" - 5/16/2015 10:02:02 AM
Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at Upcoming Medical Meetings "PR Newswire (US)" - 5/14/2015 8:00:00 AM
Why Shares of Orexigen Therapeutics, Inc. Cratered Today "The Motley Fool" - 5/13/2015 11:48:02 AM
Orexigen Terminates Required Study for Diet Drug Contrave "Dow Jones News" - 5/12/2015 5:05:54 PM
Why It's Lights Out for Orexigen Therapeutics, Inc. "The Motley Fool" - 5/12/2015 3:24:10 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/11/2015 5:44:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/11/2015 4:22:25 PM
Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2015 Financial Results "PR Newswire (US)" - 5/11/2015 4:07:00 PM
Arena Pharmaceuticals and Roivant Sciences Enter into Collaboration for Nelotanserin, a Novel Inverse Agonist of the 5-HT2A R... "PR Newswire (US)" - 5/11/2015 4:01:00 PM
Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference "PR Newswire (US)" - 5/8/2015 8:00:00 AM
Arena Pharmaceuticals to Host First Quarter 2015 Financial Results Conference Call and Webcast on Monday, May 11 "PR Newswire (US)" - 5/7/2015 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/30/2015 1:11:57 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 4/29/2015 4:26:56 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 4/29/2015 4:24:19 PM
Arena Pharmaceuticals Reports Favorable Results from Phase 1 Single-Ascending Dose Clinical Trial of APD371 "PR Newswire (US)" - 4/29/2015 8:00:00 AM
Arena Pharmaceuticals Inc.'s Plan to Win the Obesity Drug War "The Motley Fool" - 4/24/2015 8:10:02 AM
3 Promising Small-Caps Under $10 You Can Buy Right Now "The Motley Fool" - 4/21/2015 9:06:02 AM
3 Promising Healthcare Stocks Under $10 "The Motley Fool" - 4/15/2015 8:02:02 AM
Arena's 15,000 Scripts Set Pace Vs. Competitors "Seeking Alpha" - 4/13/2015 11:00:47 AM
Orexigen: Contrave Scripts Dip - Were My Concerns About Advertising Right? "Seeking Alpha" - 4/13/2015 10:23:41 AM
Arena Gets Closer On Extended Release Formulation Of Belviq "Seeking Alpha" - 4/13/2015 7:59:01 AM
The Best Stock to Invest in Obesity Drugs "The Motley Fool" - 4/12/2015 2:03:03 PM
Arena's Partner Eisai Is Slashing Jobs - What Investors Need To Consider "Seeking Alpha" - 4/10/2015 10:27:12 AM
centurycom   Saturday, 06/29/13 08:47:09 AM
Re: None
Post # of 21915 
Keep In This in Mind....

From Mötley:

"If obesity gains acceptance as a disease, it could open the doors for significant new spending on treatments. Is a payday on the way for some companies helping to fight America's new epidemic disease?

Echo effect
Before we get ahead of ourselves, keep in mind that the AMA's decision doesn't mean much on its own. No insurance company or governmental agency is obligated to begin paying for additional treatments just because the AMA now calls obesity a disease.

However, as the largest organization in the nation representing physicians, the AMA carries considerable weight (no pun intended). Already, other influential parties are echoing the decision made by the AMA.

For example, Sens. Tom Carper and Lisa Murkowski and Reps. Bill Cassidy and Ron Kind jointly wrote an op-ed piece in the New York Times commending the AMA's action. The legislators have introduced a bill in both chambers of Congress to allow Medicare to reimburse for obesity drugs and promote intensive behavioral counseling for obesity. This bill is bipartisan. Carper and Cassidy are Democrats, while Murkowski and Kind are Republicans"

-------------------------
And Remember, It was Congress who requested the HHS , and FDA do something about the obesity epidemic,before Bellviq was approved, so it is highly likely that there has been a plan all along to make obesity a disease.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist